Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway
Tao Yang,1– 4 Haiqiong Liu,1,3,4 Chaobo Yang,1,3,4 Huaqiang Mo,1,3,4 Xianbao Wang,1,3,4 Xudong Song,1,3,4 Luping Jiang,2 Ping Deng,2 Ran Chen,2 Pengcui Wu,2 Aihua Chen,1,3,4 Jing Yan1,3,4 1Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-08-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/galangin-attenuates-myocardial-ischemic-reperfusion-induced-ferroptosi-peer-reviewed-fulltext-article-DDDT |
_version_ | 1797739144825274368 |
---|---|
author | Yang T Liu H Yang C Mo H Wang X Song X Jiang L Deng P Chen R Wu P Chen A Yan J |
author_facet | Yang T Liu H Yang C Mo H Wang X Song X Jiang L Deng P Chen R Wu P Chen A Yan J |
author_sort | Yang T |
collection | DOAJ |
description | Tao Yang,1– 4 Haiqiong Liu,1,3,4 Chaobo Yang,1,3,4 Huaqiang Mo,1,3,4 Xianbao Wang,1,3,4 Xudong Song,1,3,4 Luping Jiang,2 Ping Deng,2 Ran Chen,2 Pengcui Wu,2 Aihua Chen,1,3,4 Jing Yan1,3,4 1Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Cardiovascular Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, People’s Republic of China; 3Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 4Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Jing Yan; Aihua Chen, Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, NO. 253, Gongye Avenue, Guangzhou, 510282, People’s Republic of China, Tel/Fax +86-2061643686, Email yanve1008@126.com; chenaha@126.comPurpose: Myocardial ischemic reperfusion injury (MIRI) is a crucial clinical problem globally. The molecular mechanisms of MIRI need to be fully explored to develop new therapeutic methods. Galangin (Gal), which is a natural flavonoid extracted from Alpinia Officinarum Hance and Propolis, possesses a wide range of pharmacological activities, but its effects on MIRI remain unclear. This study aimed to determine the pharmacological effects of Gal on MIRI.Methods: C57BL/6 mice underwent reperfusion for 3 h after 45 min of ischemia, and neonatal rat cardiomyocytes (NRCs) subjected to hypoxia and reoxygenation (HR) were cultured as in vivo and in vitro models. Echocardiography and TTC-Evans Blue staining were performed to evaluate the myocardial injury. Transmission electron microscope and JC-1 staining were used to validate the mitochondrial function. Additionally, Western blot detected ferroptosis markers, including Gpx4, FTH, and xCT.Results: Gal treatment alleviated cardiac myofibril damage, reduced infarction size, improved cardiac function, and prevented mitochondrial injury in mice with MIRI. Gal significantly alleviated HR-induced cell death and mitigated mitochondrial membrane potential reduction in NRCs. Furthermore, Gal significantly inhibited ferroptosis by preventing iron overload and lipid peroxidation, as well as regulating Gpx4, FTH, and xCT expression levels. Moreover, Gal up-regulated nuclear transcriptive factor Nrf2 in HR-treated NRCs. Nrf2 inhibition by Brusatol abolished the protective effect of Gal against ferroptosis.Conclusion: This study revealed that Gal alleviates myocardial ischemic reperfusion-induced ferroptosis by targeting Nrf2/Gpx4 signaling pathway.Keywords: galangin, ferroptosis, myocardial ischemia/reperfusion injury, Nrf2, Gpx4 |
first_indexed | 2024-03-12T13:53:03Z |
format | Article |
id | doaj.art-8b4245e4f5e04ced8bdd1fbc3d1bb8be |
institution | Directory Open Access Journal |
issn | 1177-8881 |
language | English |
last_indexed | 2024-03-12T13:53:03Z |
publishDate | 2023-08-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Drug Design, Development and Therapy |
spelling | doaj.art-8b4245e4f5e04ced8bdd1fbc3d1bb8be2023-08-22T20:02:53ZengDove Medical PressDrug Design, Development and Therapy1177-88812023-08-01Volume 172495251186111Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling PathwayYang TLiu HYang CMo HWang XSong XJiang LDeng PChen RWu PChen AYan JTao Yang,1– 4 Haiqiong Liu,1,3,4 Chaobo Yang,1,3,4 Huaqiang Mo,1,3,4 Xianbao Wang,1,3,4 Xudong Song,1,3,4 Luping Jiang,2 Ping Deng,2 Ran Chen,2 Pengcui Wu,2 Aihua Chen,1,3,4 Jing Yan1,3,4 1Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Cardiovascular Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, People’s Republic of China; 3Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 4Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Jing Yan; Aihua Chen, Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, NO. 253, Gongye Avenue, Guangzhou, 510282, People’s Republic of China, Tel/Fax +86-2061643686, Email yanve1008@126.com; chenaha@126.comPurpose: Myocardial ischemic reperfusion injury (MIRI) is a crucial clinical problem globally. The molecular mechanisms of MIRI need to be fully explored to develop new therapeutic methods. Galangin (Gal), which is a natural flavonoid extracted from Alpinia Officinarum Hance and Propolis, possesses a wide range of pharmacological activities, but its effects on MIRI remain unclear. This study aimed to determine the pharmacological effects of Gal on MIRI.Methods: C57BL/6 mice underwent reperfusion for 3 h after 45 min of ischemia, and neonatal rat cardiomyocytes (NRCs) subjected to hypoxia and reoxygenation (HR) were cultured as in vivo and in vitro models. Echocardiography and TTC-Evans Blue staining were performed to evaluate the myocardial injury. Transmission electron microscope and JC-1 staining were used to validate the mitochondrial function. Additionally, Western blot detected ferroptosis markers, including Gpx4, FTH, and xCT.Results: Gal treatment alleviated cardiac myofibril damage, reduced infarction size, improved cardiac function, and prevented mitochondrial injury in mice with MIRI. Gal significantly alleviated HR-induced cell death and mitigated mitochondrial membrane potential reduction in NRCs. Furthermore, Gal significantly inhibited ferroptosis by preventing iron overload and lipid peroxidation, as well as regulating Gpx4, FTH, and xCT expression levels. Moreover, Gal up-regulated nuclear transcriptive factor Nrf2 in HR-treated NRCs. Nrf2 inhibition by Brusatol abolished the protective effect of Gal against ferroptosis.Conclusion: This study revealed that Gal alleviates myocardial ischemic reperfusion-induced ferroptosis by targeting Nrf2/Gpx4 signaling pathway.Keywords: galangin, ferroptosis, myocardial ischemia/reperfusion injury, Nrf2, Gpx4https://www.dovepress.com/galangin-attenuates-myocardial-ischemic-reperfusion-induced-ferroptosi-peer-reviewed-fulltext-article-DDDTgalanginferroptosismyocardial ischemia/reperfusion injurynrf2gpx4 |
spellingShingle | Yang T Liu H Yang C Mo H Wang X Song X Jiang L Deng P Chen R Wu P Chen A Yan J Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway Drug Design, Development and Therapy galangin ferroptosis myocardial ischemia/reperfusion injury nrf2 gpx4 |
title | Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway |
title_full | Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway |
title_fullStr | Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway |
title_full_unstemmed | Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway |
title_short | Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway |
title_sort | galangin attenuates myocardial ischemic reperfusion induced ferroptosis by targeting nrf2 gpx4 signaling pathway |
topic | galangin ferroptosis myocardial ischemia/reperfusion injury nrf2 gpx4 |
url | https://www.dovepress.com/galangin-attenuates-myocardial-ischemic-reperfusion-induced-ferroptosi-peer-reviewed-fulltext-article-DDDT |
work_keys_str_mv | AT yangt galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT liuh galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT yangc galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT moh galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT wangx galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT songx galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT jiangl galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT dengp galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT chenr galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT wup galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT chena galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway AT yanj galanginattenuatesmyocardialischemicreperfusioninducedferroptosisbytargetingnrf2gpx4signalingpathway |